one month semaglutide 1.5 transformation : r/Semaglutide One month down, starting .5

Description

Designed to complement your GLP-1 journey

Adiposity & Body Composition Animal and clinical trial datasets describe substantial reductions in fat mass over 24- and 48-week protocols, with investigators attributing the magnitude to combined incretin and glucagon-receptor effects on intake and expenditure

The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157

Retatrutide (research code LY-3437943) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a novel triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIP-R), and glucagon receptor (GCG-R)

Starting semaglutide at .25mg typically produces modest weight loss in the first 48 weeks, with most patients experiencing 25 pounds of loss before dose increases